Piotr Cywoniuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Piotr Cywoniuk has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Adam Aron Mieloch
Center for Advanced Technology, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 10 Street, 61-614 Poznan, Poland
2 shared publications Jakub Dalibor Rybka
NanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, Poznań 61-614, Poland
2 shared publications- Jakub Dalibor Rybka
Center for Advanced Technology, Adam Mickiewicz University in Poznan, Poznan, Poland
2 shared publications - Katarzyna Taylor
Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Faculty of Biology Adam Mickiewicz University Poznan Poland
2 shared publications - Krzysztof Sobczak
Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznañ, Poland
2 shared publications - Lukasz J. Sznajder
Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Umultowska 89, 61-614 Poznan, Poland
2 shared publications
Latest Publications
- 4 June 2026
- Published by Elsevier in Coordination Chemistry Reviews
- Vol. 566
Metal-coordinated hydrogels for tissue engineering: A cross-class perspective on ligand design
- 4 June 2026
- Published by Elsevier in Coordination Chemistry Reviews
- Vol. 566
Metal-coordinated hydrogels for tissue engineering: A cross-class perspective on ligand design
- Open Access
- 14 September 2025
- Published by Elsevier in Food Bioscience
- Vol. 73
Immunomodulatory and antimicrobial activity of lysozyme preparations obtained by thermochemical oligomerization
- 14 September 2025
- Published by Elsevier in Food Bioscience
- Vol. 73
Open AccessImmunomodulatory and antimicrobial activity of lysozyme preparations obtained by thermochemical oligomerization
- Open Access
- 14 October 2022
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 9 (1) , 621
Formulation and evaluation of a bioink composed of alginate, gelatin, and nanocellulose for meniscal tissue engineering
The necessity to preserve meniscal function prompts the research and develop¬ment of novel treatment options, like three-dimensional (3D) bioprinting. However, bioinks for meniscal 3D bioprinting have not been extensively explored. Therefore, in this study, a bioink composed of alginate, gelatin, and carboxymethylated cellu¬lose nanocrystal (CCNC) was formulated and evaluated. Firstly, bioinks with varying concentrations of the aforementioned components were subjected to rheological analysis (amplitude sweep test, temperature sweep test, and rotation). The optimal bioink formulation of 4.0% gelatin, 0.75% alginate, and 1.4% CCNC dissolved in 4.6% D-mannitol was further used for printing accuracy analysis, followed by 3D bioprint¬ing with normal human knee articular chondrocytes (NHAC-kn). The encapsulated cells’ viability was > 98%, and collagen II expression was stimulated by the bioink. The formulated bioink is printable, stable under cell culture conditions, biocompatible, and able to maintain the native phenotype of chondrocytes. Aside from meniscal tissue bioprinting, it is believed that this bioink could serve as a basis for the devel¬opment of bioinks for various tissues.
- 14 October 2022
- Published by AccScience Publishing in International Journal of Bioprinting
- Vol. 9 (1) , 621
Open AccessFormulation and evaluation of a bioink composed of alginate, gelatin, and nanocellulose for meniscal tissue engineering
The necessity to preserve meniscal function prompts the research and develop¬ment of novel treatment options, like three-dimensional (3D) bioprinting. However, bioinks for meniscal 3D bioprinting have not been extensively explored. Therefore, in this study, a bioink composed of alginate, gelatin, and carboxymethylated cellu¬lose nanocrystal (CCNC) was formulated and evaluated. Firstly, bioinks with varying concentrations of the aforementioned components were subjected to rheological analysis (amplitude sweep test, temperature sweep test, and rotation). The optimal bioink formulation of 4.0% gelatin, 0.75% alginate, and 1.4% CCNC dissolved in 4.6% D-mannitol was further used for printing accuracy analysis, followed by 3D bioprint¬ing with normal human knee articular chondrocytes (NHAC-kn). The encapsulated cells’ viability was > 98%, and collagen II expression was stimulated by the bioink. The formulated bioink is printable, stable under cell culture conditions, biocompatible, and able to maintain the native phenotype of chondrocytes. Aside from meniscal tissue bioprinting, it is believed that this bioink could serve as a basis for the devel¬opment of bioinks for various tissues.
- Open Access
- 14 December 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 17587
Hybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions
Alternative splicing is a complex process that provides a high diversity of proteins from a limited number of protein-coding genes. It is governed by multiple regulatory factors, including RNA-binding proteins (RBPs), that bind to specific RNA sequences embedded in a specific structure. The ability to predict RNA-binding regions recognized by RBPs using whole-transcriptome approaches can deliver a multitude of data, including false-positive hits. Therefore, validation of the global results is indispensable. Here, we report the development of an efficient and rapid approach based on a modular hybrid minigene combined with antisense oligonucleotides to enable verification of functional RBP-binding sites within intronic and exonic sequences of regulated pre-mRNA. This approach also provides valuable information regarding the regulatory properties of pre-mRNA, including the RNA secondary structure context. We also show that the developed approach can be used to effectively identify or better characterize the inhibitory properties of potential therapeutic agents for myotonic dystrophy, which is caused by sequestration of specific RBPs, known as muscleblind-like proteins, by mutated RNA with expanded CUG repeats.
- 14 December 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 17587
Open AccessHybrid splicing minigene and antisense oligonucleotides as efficient tools to determine functional protein/RNA interactions
Alternative splicing is a complex process that provides a high diversity of proteins from a limited number of protein-coding genes. It is governed by multiple regulatory factors, including RNA-binding proteins (RBPs), that bind to specific RNA sequences embedded in a specific structure. The ability to predict RNA-binding regions recognized by RBPs using whole-transcriptome approaches can deliver a multitude of data, including false-positive hits. Therefore, validation of the global results is indispensable. Here, we report the development of an efficient and rapid approach based on a modular hybrid minigene combined with antisense oligonucleotides to enable verification of functional RBP-binding sites within intronic and exonic sequences of regulated pre-mRNA. This approach also provides valuable information regarding the regulatory properties of pre-mRNA, including the RNA secondary structure context. We also show that the developed approach can be used to effectively identify or better characterize the inhibitory properties of potential therapeutic agents for myotonic dystrophy, which is caused by sequestration of specific RBPs, known as muscleblind-like proteins, by mutated RNA with expanded CUG repeats.
- Open Access
- 12 October 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (21) , 10326-10342
Mechanistic determinants of MBNL activity
Muscleblind-like (MBNL) proteins are critical RNA processing factors in development. MBNL activity is disrupted in the neuromuscular disease myotonic dystrophy type 1 (DM1), due to the instability of a non-coding microsatellite in the DMPK gene and the expression of CUG expansion (CUGexp) RNAs. Pathogenic interactions between MBNL and CUGexp RNA lead to the formation of nuclear complexes termed foci and prevent MBNL function in pre-mRNA processing. The existence of multiple MBNL genes, as well as multiple protein isoforms, raises the question of whether different MBNL proteins possess unique or redundant functions. To address this question, we coexpressed three MBNL paralogs in cells at equivalent levels and characterized both specific and redundant roles of these proteins in alternative splicing and RNA foci dynamics. When coexpressed in the same cells, MBNL1, MBNL2 and MBNL3 bind the same RNA motifs with different affinities. While MBNL1 demonstrated the highest splicing activity, MBNL3 showed the lowest. When forming RNA foci, MBNL1 is the most mobile paralog, while MBNL3 is rather static and the most densely packed on CUGexp RNA. Therefore, our results demonstrate that MBNL paralogs and gene-specific isoforms possess inherent functional differences, an outcome that could be enlisted to improve therapeutic strategies for DM1.
- 12 October 2016
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 44 (21) , 10326-10342
Open AccessMechanistic determinants of MBNL activity
Muscleblind-like (MBNL) proteins are critical RNA processing factors in development. MBNL activity is disrupted in the neuromuscular disease myotonic dystrophy type 1 (DM1), due to the instability of a non-coding microsatellite in the DMPK gene and the expression of CUG expansion (CUGexp) RNAs. Pathogenic interactions between MBNL and CUGexp RNA lead to the formation of nuclear complexes termed foci and prevent MBNL function in pre-mRNA processing. The existence of multiple MBNL genes, as well as multiple protein isoforms, raises the question of whether different MBNL proteins possess unique or redundant functions. To address this question, we coexpressed three MBNL paralogs in cells at equivalent levels and characterized both specific and redundant roles of these proteins in alternative splicing and RNA foci dynamics. When coexpressed in the same cells, MBNL1, MBNL2 and MBNL3 bind the same RNA motifs with different affinities. While MBNL1 demonstrated the highest splicing activity, MBNL3 showed the lowest. When forming RNA foci, MBNL1 is the most mobile paralog, while MBNL3 is rather static and the most densely packed on CUGexp RNA. Therefore, our results demonstrate that MBNL paralogs and gene-specific isoforms possess inherent functional differences, an outcome that could be enlisted to improve therapeutic strategies for DM1.